Biopharmaceutical leader in the development of treatments for rare diseases
Education about the value of innovative new medicines.

S. 1878: "To extend the pediatric priority review voucher program". Educated staff about access to therapies for rare diseases.

Education about reimbursement for orphan drug therapies in skilled nursing facilities and proposed add-on payments in inpatient hospitals.

March 2016 CMS proposed rule implementing a new Part B drug payment model. Trans Pacific Partnership agreement with respect to data exclusivity for biologics.
HCR - Health Issues MMM - Medicare/Medicaid TRD - Trade (domestic/foreign)
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX